Clinical trial Recruiting at 1 site Interventional Ages 30 to 85 Women only

CIMT plus non-invasive cerebellar tDCS to help upper limb recovery after stroke in women

Official title: Effects of a Neurorehabilitation Program Based on Constraint-Induced Movement Therapy (CIMT) and Non-invasive Neuromodulation Through Cerebellar Transcranial Direct Current Stimulation (C-tDCS) on the Recovery of Paretic Upper Limb Function, Quality of Life, and Therapeutic Alliance in Women From the Araucanía Region Who Suffered a Stroke.

Run by Universidad de La Frontera · NCT07619703 · Data updated 2026-11-12

This study tests whether a rehabilitation program combining Constraint-Induced Movement Therapy and cerebellar tDCS can improve arm function and quality of life for women in the Araucanía region after a stroke.

More Stroke trials

Quick facts

Study typeInterventional
Ages30 Years to 85 Years
SexWomen only
Enrollment24 (estimated)
SponsorUniversidad de La Frontera
Academic / other
Locations1 site (Temuco, Araucania)
StatusRecruiting
StartedMarch 1, 2026
Main results expectedSeptember 1, 2026
Study endsDecember 31, 2026
Registry record updatedJune 3, 2026
Trial IDNCT07619703 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Women aged 30–80 who have had a stroke at least one month prior, with some trunk control and adequate cognitive function.

Probably not a fit

Individuals with significant shoulder pain, high spasticity, sensory deficits, aphasia, certain implants, recent psychiatric disorders, or pregnancy may not benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This single-blind randomized trial will compare a CIMT-based rehab program with and without cerebellar transcranial direct current stimulation in women who have had a stroke. Participants will undergo 10 sessions over two weeks and be assessed at five time points for upper-limb function, quality of life, and therapeutic alliance. Outcomes include motor capacity tests, daily-use measures, and patient-reported quality of life. The trial aims to determine if adding C-tDCS to CIMT provides additional benefit beyond CIMT alone. Data collection will occur at pre-treatment, mid-treatment, post-treatment, and during two follow-up visits.

Why it matters

Potential benefit: If successful, participants may experience greater improvements in arm function and overall quality of life after stroke.

How similar studies have gone: Prior studies in neurorehabilitation suggest CIMT and non-invasive neuromodulation can improve motor outcomes, but the specific combination with cerebellar tDCS in this population is novel/less established.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Women aged between 30 and 80 years.
* Who present hemorrhagic or ischemic stroke confirmed by CT with evolution greater than 1 month, corroborated by discharge epicrisis supporting the diagnosis of the patient.
* Who presents trunk control in sitting.
* Score greater than 14 points on the Minimental Examination scale.
* Function of the upper extremity, referring to taking and releasing a small ball with the affected hand and signing or accepting the consent written informed.

Exclusion Criteria:

* Shoulder pain greater than 4 according to the VAS scale and spasticity greater than 2 according to the Modified Ashworth Scale.
* Sensory compromise (visual-auditory).
* Presence of severe aphasia.
* Cochlear implants, aneurysm clips, brain electrodes and cardiac pacemaker.
* Epilepsy or psychiatric disorders (diagnosed in the last 3 months).
* Pregnancy, use of psychotropic medications.

Where it's running

  • Universidad de La Frontera, Temuco, Chile.
    Temuco, Araucania, Chile
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.